Professor Ming-Wei Wang, Director of the National Center for Drug Screening and the Chinese National Compound Library (CNCL), visited Beijing Shenogen Pharma Group, Ltd. in the afternoon of May 25, 2015. He broadly exchanged views and propositions concerning participation by innovative small- and mid-size enterprises in the development of national compound resource platform with Drs. Kun Meng (CEO), Jun Bao (CBO), Xaio Shang (Senior Vice President), Qingchong Lin (Vice President) and Junma Zhou (Executive Director).